Carla L Black1, Walter W Williams2, Inaki Arbeloa3, Natasa Kordic3, Lindsay Yang3, Tom MaCurdy3, Chris Worrall4, Jeffrey A Kelman4. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: zwc0@cdc.gov. 2. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA. 3. Acumen, LLC, Burlingame, CA. 4. Center for Medicare, Centers for Medicare & Medicaid Services, Baltimore, MD.
Abstract
BACKGROUND: Institutionalized adults are at increased risk of morbidity and mortality from influenza and pneumococcal infection. Influenza and pneumococcal vaccination have been shown to be effective in reducing hospitalization and deaths due to pneumonia and influenza in this population. OBJECTIVE: To assess trends in influenza vaccination coverage among US nursing home residents from the 2005-2006 through 2014-2015 influenza seasons and trends in pneumococcal vaccination coverage from 2006 to 2014 among US nursing home residents, by state and demographic characteristics. METHODS: Data were analyzed from the Centers for Medicare and Medicaid Services' (CMS's) Minimum Data Set (MDS). Influenza and pneumococcal vaccination status were assessed for all residents of CMS-certified nursing homes using data reported to the MDS by all certified facilities. RESULTS: Influenza vaccination coverage increased from 71.4% in the 2005-2006 influenza season to 75.7% in the 2014-2015 influenza season and pneumococcal vaccination coverage increased from 67.4% in 2006 to 78.4% in 2014. Vaccination coverage varied by state, with influenza vaccination coverage ranging from 50.0% to 89.7% in the 2014-2015 influenza season and pneumococcal vaccination coverage ranging from 55.0% to 89.7% in 2014. Non-Hispanic black and Hispanic residents had lower coverage compared with non-Hispanic white residents for both vaccines, and these differences persisted over time. CONCLUSION: Influenza and pneumococcal vaccination among US nursing home residents remains suboptimal. Nursing home staff can employ strategies such as provider reminders and standing orders to facilitate offering vaccination to all residents along with culturally appropriate vaccine promotion to increase vaccination coverage among this vulnerable population. Published by Elsevier Inc.
BACKGROUND: Institutionalized adults are at increased risk of morbidity and mortality from influenza and pneumococcal infection. Influenza and pneumococcal vaccination have been shown to be effective in reducing hospitalization and deaths due to pneumonia and influenza in this population. OBJECTIVE: To assess trends in influenza vaccination coverage among US nursing home residents from the 2005-2006 through 2014-2015 influenza seasons and trends in pneumococcal vaccination coverage from 2006 to 2014 among US nursing home residents, by state and demographic characteristics. METHODS: Data were analyzed from the Centers for Medicare and Medicaid Services' (CMS's) Minimum Data Set (MDS). Influenza and pneumococcal vaccination status were assessed for all residents of CMS-certified nursing homes using data reported to the MDS by all certified facilities. RESULTS: Influenza vaccination coverage increased from 71.4% in the 2005-2006 influenza season to 75.7% in the 2014-2015 influenza season and pneumococcal vaccination coverage increased from 67.4% in 2006 to 78.4% in 2014. Vaccination coverage varied by state, with influenza vaccination coverage ranging from 50.0% to 89.7% in the 2014-2015 influenza season and pneumococcal vaccination coverage ranging from 55.0% to 89.7% in 2014. Non-Hispanic black and Hispanic residents had lower coverage compared with non-Hispanic white residents for both vaccines, and these differences persisted over time. CONCLUSION: Influenza and pneumococcal vaccination among US nursing home residents remains suboptimal. Nursing home staff can employ strategies such as provider reminders and standing orders to facilitate offering vaccination to all residents along with culturally appropriate vaccine promotion to increase vaccination coverage among this vulnerable population. Published by Elsevier Inc.
Authors: Peng-Jun Lu; Alissa O'Halloran; Leah Bryan; Erin D Kennedy; Helen Ding; Samuel B Graitcer; Tammy A Santibanez; Ankita Meghani; James A Singleton Journal: Am J Infect Control Date: 2014-05-03 Impact factor: 2.918
Authors: Jill A Marsteller; Ronald B Tiggle; Robin E Remsburg; Barbara Bardenheier; Abigail Shefer; Beth Han Journal: J Am Med Dir Assoc Date: 2008-09-25 Impact factor: 4.669
Authors: Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; Carolyn B Bridges; David K Kim; Tamara Pilishvili; Craig M Hales; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-06 Impact factor: 17.586
Authors: Kevin W McConeghy; Yoojin Lee; Andrew R Zullo; Geetanjoli Banerjee; Lori Daiello; David Dosa; Douglas P Kiel; Vincent M Mor; Sarah D Berry Journal: J Gerontol A Biol Sci Med Sci Date: 2018-11-10 Impact factor: 6.053
Authors: Joe B B Silva; Elliott Bosco; Melissa R Riester; Kevin W McConeghy; Patience Moyo; Robertus van Aalst; Barbara H Bardenheier; Stefan Gravenstein; Rosa Baier; Matthew M Loiacono; Ayman Chit; Andrew R Zullo Journal: J Am Geriatr Soc Date: 2021-05-20 Impact factor: 7.538
Authors: Elliott Bosco; Andrew R Zullo; Kevin W McConeghy; Patience Moyo; Robertus van Aalst; Ayman Chit; Kevin M Mwenda; Catherine A Panozzo; Vincent Mor; Stefan Gravenstein Journal: Clin Infect Dis Date: 2020-11-05 Impact factor: 9.079
Authors: Barbara H Bardenheier; Rosa R Baier; Joe B Silva; Stefan Gravenstein; Patience Moyo; Elliott Bosco; Jessica Ogarek; Robertus van Aalst; Ayman Chit; Matthew Loiacono; Andrew R Zullo Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Patience Moyo; Elliott Bosco; Barbara H Bardenheier; Maricruz Rivera-Hernandez; Robertus van Aalst; Ayman Chit; Stefan Gravenstein; Andrew R Zullo Journal: Vaccine Date: 2022-01-13 Impact factor: 3.641
Authors: Reem T Mulla; Luke Andrew Turcotte; Nathalie Ih Wellens; Milou J Angevaare; Julie Weir; Micaela Jantzi; Paul C Hébert; George A Heckman; Hein van Hout; Nigel Millar; John P Hirdes Journal: BMJ Open Date: 2022-04-18 Impact factor: 3.006
Authors: Arielle Childs; Andrew R Zullo; Nina R Joyce; Kevin W McConeghy; Robertus van Aalst; Patience Moyo; Elliott Bosco; Vincent Mor; Stefan Gravenstein Journal: BMC Geriatr Date: 2019-08-05 Impact factor: 3.921
Authors: Patience Moyo; Andrew R Zullo; Kevin W McConeghy; Elliott Bosco; Robertus van Aalst; Ayman Chit; Stefan Gravenstein Journal: BMC Geriatr Date: 2020-02-10 Impact factor: 3.921